pre-miRNA Information
pre-miRNA mmu-mir-92a-1   
Genomic Coordinates chr14: 115044427 - 115044506
Description Mus musculus miR-92a-1 stem-loop
Comment The predominant miR-92 form cloned by Landgraf et al. has a additional 3' U residue, which is compatible with this precursor sequence, but not with that of mir-92-2 (MIR:MI0000580) .
RNA Secondary Structure
pre-miRNA mmu-mir-92a-2   
Genomic Coordinates chrX: 52741838 - 52741928
Description Mus musculus miR-92a-2 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA mmu-miR-92a-3p
Sequence 50| UAUUGCACUUGUCCCGGCCUG |70
Evidence Experimental
Experiments Cloned
Putative Targets

Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BE2BW7 miR-92a-3p Monitoring Biomarker (MOI) Clinical/Experimental Data Expression Increase Plasma Polymerase chain reaction
Gene Information
Gene Symbol Tagap   
Synonyms 2610315E15Rik
Description T cell activation Rho GTPase activating protein
Transcript NM_145968   
Expression
Putative miRNA Targets on Tagap
3'UTR of Tagap
(miRNA target sites are highlighted)
>Tagap|NM_145968|3'UTR
   1 GAAAGCCTTGTACCATGGCTAACTTGTGTGTGAAGATGCGACTGCAGAGAACTGTCTGTTGAGTCACAGATAAGCTCATT
  81 CAGAACTCAGTGTGCGGCTCTCCTCTGTGAGGATGGCTCACACGGTGACACCAAATTTTGCCTGTGTGTAACCGGGTTTG
 161 TGCAATATGTAGTAAATGTATAAAATGTATTATTATATGCAAGGTATTAGATGCAAAGGGTGTCTGCGTACATCCCTTCA
 241 TGCATTCACTTCTGTATGTTGTTTTTTTGTCCTCAGGCACTTGTTTCTATTAAGTAGAAAGAGTTTTTACTTTTCTTAAT
 321 GTTACAGCAAATGCCATGCCTGTGTTCACATTAGCCGCCAGCTGCATGTAGGTGGAAATGTCTGAGCCTCTGATGCATCT
 401 TCTCCTAAGCAGGCTTGAGACGAGTCAGCATCATAGAAGGGAACAGACTGGAAGACACTGTACTTGGTGTGTGACCCATC
 481 AGCCGCACTGGGAGAAGGTCTTTCAGTCATCTAATGGAATGTGGGTGGCGTGGTGGAAATGCATTCTGTTAGTAGTAACT
 561 CACGCAGAGTACTTTGAGCCTCTGCAGCTCAGTCATGTCTTGTGCAGCTGTGTAGTGGTAAGCACTGTTGTATGCATTGG
 641 GGAGTCTTGTATAAGACTTCAGTAGAGTTTATTTATTAGTCACAATAAACTGCCCTCCTCCTTTAGACAGTTTATTACTT
 721 GCTGATGTTATATCCTTTGCCTCAAATAAAAATCCGCCAAGAACATTA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' guccGGCCCUGUUCACGUUAu 5'
              ||||| :  ||||||| 
Target 5' gtaaCCGGG-TTTGTGCAATa 3'
148 - 167 152.00 -21.00
2
miRNA  3' guCCGGCCCUGUU--CACGUUAu 5'
            | |: | :||:  |||:|:| 
Target 5' atGTCTTGTGCAGCTGTGTAGTg 3'
595 - 617 117.00 -9.50
3
miRNA  3' guccggCCCUGUUC-ACGUUau 5'
                || |: || |||||  
Target 5' atgcaaGGTATTAGATGCAAag 3'
197 - 218 103.00 -8.40
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions CD4+ T cells (C57BL/6)
Disease MIMAT0000539
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "HITS-CLIP data was present in GSM1013580. RNA binding protein: AGO2. Condition:CD4+ T cells ...

- Loeb GB; Khan AA; Canner D; Hiatt JB; et al., 2012, Molecular cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' guccGGCCCUGUUCACGUUAu 5'
              ||||| :  ||||||| 
Target 5' guaaCCGGG-UUUGUGCAAUa 3'
21 - 40
Article - Loeb GB; Khan AA; Canner D; Hiatt JB; et al.
- Molecular cell, 2012
MicroRNAs (miRNAs) are essential components of gene regulation, but identification of miRNA targets remains a major challenge. Most target prediction and discovery relies on perfect complementarity of the miRNA seed to the 3' untranslated region (UTR). However, it is unclear to what extent miRNAs target sites without seed matches. Here, we performed a transcriptome-wide identification of the endogenous targets of a single miRNA-miR-155-in a genetically controlled manner. We found that approximately 40% of miR-155-dependent Argonaute binding occurs at sites without perfect seed matches. The majority of these noncanonical sites feature extensive complementarity to the miRNA seed with one mismatch. These noncanonical sites confer regulation of gene expression, albeit less potently than canonical sites. Thus, noncanonical miRNA binding sites are widespread, often contain seed-like motifs, and can regulate gene expression, generating a continuum of targeting and regulation.
LinkOut: [PMID: 23142080]
24 mmu-miR-92a-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT002971 Hipk3 homeodomain interacting protein kinase 3 2 1
MIRT002978 Mylip myosin regulatory light chain interacting protein 3 1
MIRT004280 Trp63 transformation related protein 63 4 1
MIRT007244 Map2k4 mitogen-activated protein kinase kinase 4 1 1
MIRT053813 Zfpm2 zinc finger protein, multitype 2 3 1
MIRT054699 Tbx3 T-box 3 3 2
MIRT054792 Shox2 short stature homeobox 2 1 1
MIRT578185 Ncam2 neural cell adhesion molecule 2 1 1
MIRT580680 Stk10 serine/threonine kinase 10 1 3
MIRT583677 Fam136a family with sequence similarity 136, member A 1 1
MIRT584193 Cpeb1 cytoplasmic polyadenylation element binding protein 1 1 1
MIRT587067 Gm5148 predicted gene 5148 1 2
MIRT589036 Rhbdl3 rhomboid, veinlet-like 3 (Drosophila) 1 1
MIRT595174 Zpbp zona pellucida binding protein 1 1
MIRT595805 Chm choroidermia (RAB escort protein 1) 1 1
MIRT595903 Cd69 CD69 antigen 1 1
MIRT596292 Tagap1 T cell activation GTPase activating protein 1 1 1
MIRT596301 Tagap T cell activation Rho GTPase activating protein 1 1
MIRT596475 Btg2 B cell translocation gene 2, anti-proliferative 1 1
MIRT598598 Il5ra interleukin 5 receptor, alpha 1 1
MIRT598840 Gm14420 zinc finger protein 970 1 1
MIRT601409 Uba1y ubiquitin-activating enzyme, Chr Y 1 1
MIRT606063 Zfp300 zinc finger protein 300 1 1
MIRT735310 PTEN phosphatase and tensin homolog 3 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-92a Vorinostat (SAHA) approved 5311 Microarray A549 human non-small cell lung cancer cells 19513533 2009 down-regulated
miR-92a 5-Fluorouracil approved 3385 Microarray HCT-116 colon cancer cell line 19956872 2010 down-regulated
miR-92a 5-Fluorouracil approved 3385 Microarray HCT-8 colon cancer cell line 19956872 2010 down-regulated
miR-92a 5-Fluorouracil approved 3385 Quantitative real-time PCR HCT-116 colon cancer cell line 19956872 2010 down-regulated
miR-92a 5-Fluorouracil approved 3385 Quantitative real-time PCR HCT-8 colon cancer cell line 19956872 2010 down-regulated
miR-92a Oxaliplatin (L-OHP) approved 5310940 Microarray HCT-116 colon cancer cell line 19956872 2010 down-regulated
miR-92a Oxaliplatin (L-OHP) approved 5310940 Quantitative real-time PCR HCT-8 colon cancer cell line 19956872 2010 down-regulated
miR-92a 3,3'-diindolylmethane (BR-DIM) NULL 3071 Quantitative real-time PCR Prostatic cancer 22412975 2012 down-regulated
miR-92a Isoflavone NULL 72304 Quantitative real-time PCR Prostatic cancer 22412975 2012 down-regulated
miR-92a Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) NULL 8490 Microarray mouse liver 19270793 2009 down-regulated
miR-92a Comfrey NULL 6440495 Microarray rat liver 21370286 2011 down-regulated
miR-92a Comfrey NULL 6440495 Quantitative real-time PCR rat liver 21370286 2011 down-regulated
miR-92a Dexamethasone approved 5743 Microarray adrenals and granulosa cells 24205079 2014 down-regulated
miR-92a Perfluorooctane sulfonate NULL 74483 Microarray zebrafish embryos 20878907 2011 down-regulated

Error report submission